Fidelity Disruptive Medicine ETF (FMED) Short Interest Ratio & Short Volume

Short interest is the volume of Fidelity Disruptive Medicine ETF shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 12,800 shares of FMED short. Learn More on Fidelity Disruptive Medicine ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FMED shares currently have a short interest ratio of 2.0. Learn More on Fidelity Disruptive Medicine ETF's short interest ratio.

Fidelity Disruptive Medicine ETF saw a increase in short interest in October. As of October 31st, there was short interest totaling 12,800 shares, an increase of 29.3% from the previous total of 9,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Fidelity Disruptive Medicine ETF: Spear Alpha ETF (0.10%), AOT Growth & Innovation ETF (0.03%), Tradr 2X Short Innovation Daily ETF (30.87%), Fidelity Disruptive Communications ETF (2.31%), Global X E-Commerce ETF (0.03%), Global X Aging Population ETF (0.06%), Tema Oncology ETF (0.06%), Invesco ESG NASDAQ 100 ETF (1.49%), Global X Telemedicine & Digital Health ETF (0.13%), Roundhill GLP-1 & Weight Loss ETF (0.89%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling FMED is an investing strategy that aims to generate trading profit from Fidelity Disruptive Medicine ETF as its price is falling. FMED shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Fidelity Disruptive Medicine ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FMED, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FMED, twice per month. The most recent reporting period available is October, 31 2024.